Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 26 studies | 27% ± 10% | |
astrocyte | 18 studies | 35% ± 14% | |
oligodendrocyte | 16 studies | 43% ± 20% | |
smooth muscle cell | 10 studies | 21% ± 3% | |
type II pneumocyte | 10 studies | 28% ± 11% | |
glutamatergic neuron | 10 studies | 44% ± 18% | |
oligodendrocyte precursor cell | 10 studies | 35% ± 17% | |
type I pneumocyte | 9 studies | 26% ± 8% | |
adipocyte | 8 studies | 24% ± 5% | |
endothelial cell of lymphatic vessel | 7 studies | 23% ± 2% | |
basal cell | 7 studies | 21% ± 4% | |
endothelial cell | 6 studies | 35% ± 11% | |
interneuron | 6 studies | 42% ± 22% | |
myofibroblast cell | 6 studies | 29% ± 6% | |
GABAergic neuron | 6 studies | 36% ± 9% | |
abnormal cell | 5 studies | 23% ± 3% | |
neuron | 5 studies | 37% ± 15% | |
connective tissue cell | 5 studies | 21% ± 4% | |
epithelial cell | 5 studies | 25% ± 10% | |
adventitial cell | 5 studies | 23% ± 2% | |
ciliated cell | 5 studies | 18% ± 2% | |
club cell | 5 studies | 18% ± 2% | |
granule cell | 4 studies | 32% ± 11% | |
progenitor cell | 3 studies | 31% ± 3% | |
retinal pigment epithelial cell | 3 studies | 29% ± 10% | |
Mueller cell | 3 studies | 22% ± 3% | |
erythrocyte | 3 studies | 23% ± 1% | |
ependymal cell | 3 studies | 48% ± 15% | |
chondrocyte | 3 studies | 28% ± 5% | |
goblet cell | 3 studies | 37% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 14096.33 | 245 / 245 | 100% | 213.78 | 502 / 502 |
brain | 100% | 14146.14 | 2636 / 2642 | 100% | 317.51 | 702 / 705 |
ovary | 100% | 10002.46 | 180 / 180 | 98% | 140.56 | 423 / 430 |
esophagus | 100% | 9849.15 | 1444 / 1445 | 96% | 75.11 | 175 / 183 |
thymus | 99% | 7026.47 | 649 / 653 | 94% | 67.25 | 568 / 605 |
stomach | 98% | 6201.51 | 353 / 359 | 93% | 73.12 | 265 / 286 |
intestine | 96% | 8974.10 | 929 / 966 | 94% | 56.09 | 494 / 527 |
breast | 100% | 10573.07 | 459 / 459 | 89% | 86.46 | 991 / 1118 |
skin | 100% | 14263.03 | 1809 / 1809 | 81% | 53.80 | 381 / 472 |
lung | 100% | 7413.94 | 576 / 578 | 71% | 43.31 | 816 / 1155 |
uterus | 100% | 16419.38 | 170 / 170 | 68% | 50.44 | 314 / 459 |
bladder | 100% | 9407.10 | 21 / 21 | 48% | 23.27 | 243 / 504 |
adrenal gland | 83% | 2774.18 | 214 / 258 | 34% | 15.66 | 78 / 230 |
pancreas | 28% | 752.12 | 91 / 328 | 88% | 42.29 | 157 / 178 |
blood vessel | 100% | 15379.34 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 22481.43 | 803 / 803 | 0% | 0 | 0 / 0 |
adipose | 100% | 9576.28 | 1203 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 96.88 | 79 / 80 |
liver | 43% | 1180.58 | 97 / 226 | 52% | 25.55 | 211 / 406 |
heart | 95% | 6292.47 | 817 / 861 | 0% | 0 | 0 / 0 |
kidney | 28% | 980.08 | 25 / 89 | 57% | 26.95 | 515 / 901 |
tonsil | 0% | 0 | 0 / 0 | 76% | 37.34 | 34 / 45 |
spleen | 17% | 467.27 | 40 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 14% | 415.26 | 127 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006260 | Biological process | DNA replication |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | NFIX |
Protein name | Nuclear factor 1 X-type (NF1-X) (Nuclear factor 1/X) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/X) (NF-I/X) (NFI-X) (TGGCA-binding protein) Nuclear factor I X Nuclear factor 1 CCAAT-box-binding transcription factor (TGGCA-binding protein) |
Synonyms | |
Description | FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . |
Accessions | ENST00000676441.1 K7EMQ5 B4DHW2 ENST00000586797.5 A0A087WXP2 A0A8J8YL86 C9JWJ8 ENST00000358552.8 K7EPU2 K7EJB0 K7ESG9 Q14938 ENST00000585382.5 ENST00000397661.6 [Q14938-3] ENST00000590027.1 ENST00000586873.1 ENST00000585575.5 [Q14938-4] ENST00000587760.5 [Q14938-6] K7EKH0 ENST00000360105.8 ENST00000592199.6 [Q14938-1] ENST00000693124.1 ENST00000588228.5 ENST00000622520.2 A0A8I5KYE6 ENST00000587260.1 [Q14938-5] K7EN08 ENST00000591028.1 |